GARRISON BRADFORD & ASSOCIATES INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 143 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
GARRISON BRADFORD & ASSOCIATES INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$109,000
-59.6%
87,7000.0%0.09%
-60.5%
Q1 2017$270,000
-14.8%
87,700
+12.9%
0.24%
-18.5%
Q4 2016$317,000
-39.6%
77,700
-6.0%
0.29%
-40.9%
Q3 2016$525,000
+17.7%
82,7000.0%0.49%
+13.0%
Q2 2016$446,000
-35.5%
82,7000.0%0.44%
-45.7%
Q1 2016$692,000
+6.0%
82,7000.0%0.80%
+10.0%
Q4 2015$653,000
-7.2%
82,7000.0%0.73%
-5.8%
Q3 2015$704,000
-37.3%
82,700
-8.8%
0.78%
-29.1%
Q2 2015$1,122,000
+4.1%
90,7000.0%1.10%
+8.8%
Q1 2015$1,078,000
+5.2%
90,7000.0%1.01%
+8.4%
Q4 2014$1,025,000
+22.9%
90,700
-4.5%
0.93%
+11.4%
Q3 2014$834,000
+16.8%
95,001
-3.1%
0.83%
+25.6%
Q2 2014$714,000
+44.5%
98,0010.0%0.66%
+39.5%
Q1 2014$494,000
-5.4%
98,0010.0%0.48%
-3.4%
Q4 2013$522,000
+40.7%
98,0010.0%0.49%
+29.7%
Q3 2013$371,000
-43.9%
98,0010.0%0.38%
-46.6%
Q2 2013$661,00098,0010.71%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders